GPT and metabolic dysfunction-associated steatohepatitis: In Main group, in patients with NASH (n = 28), ALT/AST levels at all tested days significantly decreased from baseline (P < 0.025) to normal at the 6-week follow-up, while in Controls the levels did not reach normal at the 6-week follow-up (Table 2).